Doylestown, PA, United States of America

Kenneth M Wells

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Merck + Co., Inc., Janssen Pharmaceutica Nv, Mitsubishi Tanabe Pharma Corporation. Active years: 1997-2016.

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 77.8

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 75(Granted Patents)

Location History:

Somerville, NJ (US) (1997 - 1999)
Neshanic Station, NJ (US) (1999 - 2002)
Raritan, NJ (US) (2012 - 2014)
Hillsborough, NJ (US) (2006 - 2015)
Doylestown, PA (US) (2014 - 2016)

Company Filing History:

Janssen Pharmaceutica Nv

patents

1 out of 263

Mitsubishi Tanabe Pharma Corporation

patents

where one patent can have more than one assignee

Years Active: 1997-2016

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9522931 - Process for the preparation of compounds useful as inhibitors of SGLT-2 (2016-12-20),

2. 9434711 - Sulfonamides as TRPM8 modulators (2016-09-06),

3. 9024009 - Process for the preparation of compounds useful as inhibitors of SGLT (2015-05-05),

4. 8835417 - Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone (2014-09-16),

5. 8809327 - Sulfonamides as TRPM8 modulators (2014-08-19),

6. 8153682 - Sulfonamides as TRPM8 modulators (2012-04-10),

7. 7951829 - Benzimidazole modulators of VR1 (2011-05-31),

8. 7074930 - Amine salts of an integrin receptor antagonist (2006-07-11),

9. 6407241 - Process and intermediates for the preparation of imidazolidinone &agr;v integrin antagonists (2002-06-18),

10. 6346617 - Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof (2002-02-12),

11. 6194568 - Process for synthesizing carbapenem intermediates (2001-02-27),

12. 5922906 - Side chains synthesis for an anthiarrhythmic compound (1999-07-13),

13. 5919937 - Process for phosphodiesterase IV inhibitors (1999-07-06),

14. 5861512 - Process for making HIV protese inhibitors (1999-01-19),

15. 5777123 - Process for regioselective substitution of trifluorobenzoate or (1998-07-07),

Title: The Innovative Journey of Kenneth M Wells

Introduction:

Kenneth M Wells, a distinguished inventor hailing from Doylestown, PA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Kenneth M Wells holds several patents in various technological domains, including advancements in renewable energy systems, smart home automation, and medical devices.

Career Highlights:

With a career spanning over two decades, Kenneth M Wells has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations:

Throughout his career, Kenneth M Wells has collaborated with leading research institutions, universities, and technology companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Kenneth M Wells stands as a testament to the power of innovation and perseverance in the world of technology. His passion for creating solutions that make a difference sets him apart as a true pioneer in the field of inventions.